LONDON, May 24, 2022 (GLOBE NEWSWIRE) — According to The Business Research Company’s research report on Artificial Intelligence (AI) in the drug discovery market, the growing adoption of applications and services based on the cloud by pharmaceutical companies will contribute to the growth of AI in the drug discovery market. Among the various end users of cloud-based drug discovery platforms, pharmaceutical vendors are likely to be major stakeholders, holding high value share of the global cloud-based drug discovery platforms market. An analysis of global market opportunities reveals that leading software vendors have already adopted cloud-based drug discovery platforms to facilitate seamless research and development processes. Additionally, the cloud-based drug discovery platform revolution will see significant growth in the coming years, creating better opportunities for software companies to grow and expand. For example, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced in December 2021 that it was collaborating with Pfizer to develop innovative cloud-based solutions that have the potential to improve the way new drugs are developed, manufactured and distributed for clinical trials. Companies are exploring these advancements through their new Pfizer Amazon Collaboration Team (PACT) initiative, which applies AWS capabilities in analytics, machine learning, compute, storage, security, and data warehousing in the cloud to Pfizer laboratory, clinical manufacturing and clinical supply chain. efforts. Thus, the growing adoption of cloud-based applications and services by pharmaceutical companies will positively contribute to the AI ​​drug discovery market size.

Request for a sample of the world artificial intelligence (AI) in drug discovery market report

The global artificial intelligence in drug discovery market size is expected to grow from $0.79 bmillion in 2021 at $1.04 bmillion in 2022 at a compound annual growth rate (CAGR) of 31.6%. The market growth is mainly driven by businesses resuming operations and adapting to the new normal while recovering from the impact of COVID-19, which previously led to restrictive lockdown measures involving social distancing , remote working and closing business activities. which resulted in operational difficulties. The AI ​​in Drug Discovery Market is Expected to Reach $2.99 bmillion in 2026 to CAGR of 30.2%.

The use of AI through machine learning (ML) is a trend in the evaluation of preclinical studies during the drug development process. Preclinical studies are non-clinical studies of new drug substances aimed at establishing clinical efficacy and safety in a controlled environment before testing them in a final target population. Pharmacokinetic (PK) and pharmacodynamic (PD) ML modeling methodologies are applied in in vitro and preclinical PK studies to successfully anticipate the dose-concentration-response relationship of pipeline assets. Furthermore, deep learning methodologies are used as “in-silico” methods to successfully predict the therapeutic/pharmacological properties of novel molecules using transcriptomic data, which includes various biological systems and controlled conditions. Apart from the drug discovery market, machine learning technology finds application in the AI ​​market in medical diagnostics as well as AI in medical imaging market.

Major players in the Artificial Intelligence for Drug Discovery and Development market include IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica, and BIOAGE.

The global Artificial Intelligence in Drug Discovery market report is segmented by Deep Learning Technology, Machine Learning; by drug type in small molecules, large molecules; by type of disease in metabolic diseases, cardiovascular diseases, oncology, neurodegenerative diseases, others; by end users in pharmaceutical companies, biopharmaceutical companies, academic and research institutes, etc.

In 2021, North America was the greater region in the artificial intelligence (AI) in drug discovery market. It was followed by Asia-Pacific, Western Europe, and then the other regions. Regions covered in the AI ​​in Drug Discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Artificial Intelligence (AI) in Drug Discovery Global Market Report 2022 – Global Market Size, Trends and Forecasts 2022-2026 is part of a series of new reports from The Business Research Company that provide the Artificial Intelligence (AI) in Drug Discovery Market Overview, Artificial Intelligence (AI) in Drug Discovery Market Analyze and Forecast Market Size and Growth for Overall Market, Artificial Intelligence (AI) ) in Drug Discovery Market segments and geographies, Artificial Intelligence (AI) in Drug Discovery Market Trends, Artificial Intelligence (AI) in Drug Discovery Market Drivers, the Artificial Intelligence (AI) in Drug Discovery Market Constraints, Artificial Intelligence (AI) in Drug Discovery Revenue, Profiles and Share drug discovery market leading competitors in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives an in-depth analysis of the impact of COVID-19 on the market. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. A highly experienced and expert team of analysts and modellers provide market analysis and forecasts. The reports identify key countries and segments for opportunities and strategies based on market trends and key competitor approaches.

Not the market you are looking for? To verify some ssimilar market intelligence reports:

AI In Pharma Global Market Report 2022 – By Technology (Context Aware Processing, Natural Language Processing, Query Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnostics, Clinical Trials, Drug Discovery, Research and Development, Epidemic Forecasting) – Global Market Size, Trends and Forecasts 2022-2026

Global Artificial Intelligence in Healthcare Market Report 2022 – By Offer (Hardware, Software), By Algorithms (Deep Learning, Query Method, Natural Language Processing, Context Aware Processing), By Application (robot-assisted surgery, virtual nurse assistant, administrative workflow support, fraud detection, dosing error reduction, clinical trial participant ID, preliminary diagnosis), per end user (hospitals and diagnostic centers, pharmaceutical and biopharmaceutical companies, healthcare payers, patients) – Global market size, trends and forecasts 2022-2026

Global Cloud Services Market Report 2022 – By Type (Software as a Service (SaaS), Platform as a Service (PaaS), Infrastructure as a Service (IaaS), Business Process as a Service (BPaaS) )), by end-user industry (BFSI, Media & Entertainment, IT & Telecom, Energy & Utilities, Government & Public Sector, Retail & Consumer Goods, Manufacturing), by Application (Storage, Backup & Recovery disaster recovery, application development and testing, database management, business analytics, integration and orchestration, customer relationship management), by deployment model (public cloud, private cloud, hybrid cloud), by organization size (Large Enterprises, Small & Medium Enterprises) – Global Market Size, Trends & Forecast 2022-2026

Want to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in business, market and consumer research. Located around the world, it has consultants specializing in a wide range of industries, including manufacturing, healthcare, financial services, chemicals and technology.

The most comprehensive database in the world

The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and measures across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess gaps between supply and demand.